Adaza, Raffy D.

HRN: 29-08-70  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
CO-AMOXICLAV 625MG (TAB)
06/02/2026
06/09/2026
PO
625mg
BID
Lacerated Wound
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines